Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 175 entries
View as:

CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03473457 Org: User:
Start: 04/01/18 End: 12/31/20 Due: 12/31/21

Observation on the Correlation Between Serum/Fecal Isoflavones, Abundance of TMA-producing Bacteria and Serum TMAO in Hyperlipidemia and Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06890780 Org: User:
Start: 01/01/23 End: 12/31/25 Due: 12/31/26

A Randomized Controlled Trial of the Efficacy of the Lighthouse Parenting Programme in Addressing Parenting Difficulties in China

Phase: N/A Priority: Normal
NCT ID: NCT06858059 Org: User:
Start: 03/10/25 End: 12/13/25 Due: 12/13/26

DNA Methylation and the Increased Risk of Cervical Cancer Development

Phase: N/A Priority: Normal
NCT ID: NCT06859151 Org: User:
Start: 03/20/25 End: 12/30/26 Due: 12/30/27

Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT06861114 Org: User:
Start: 02/20/25 End: 12/31/27 Due: 12/31/28

An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04997252 Org: User:
Start: 02/01/21 End: 12/31/24 Due: 12/31/25

Validation of the Accuracy of a Novel POCT Dry Blood Gas Analyzer in Acute Care Settings

Phase: N/A Priority: Normal
NCT ID: NCT06726473 Org: User:
Start: 12/20/24 End: 01/31/25 Due: 01/31/26

Effects of Inspiratory and Expiratory Pressure Training Methods in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02326181 Org: User:
Start: 01/31/15 End: 12/31/16 Due: 12/31/17

The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT03180697 Org: User:
Start: 06/03/17 End: 10/01/21 Due: 10/01/22

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

Phase: N/A Priority: Normal
NCT ID: NCT05638269 Org: User:
Start: 03/01/22 End: 12/31/25 Due: 12/31/26

Compared With 2 Different Ablation Strategies Clinical Outcome for Treating Patients With Paroxysmal Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT03190395 Org: User:
Start: 01/20/19 End: 08/31/21 Due: 08/31/22

Improvement of Organ Function by Apigenin in Elderly Patients With Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT05999682 Org: User:
Start: 09/01/23 End: 01/05/24 Due: 01/05/25

Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06902012 Org: User:
Start: 02/28/27 End: 08/31/28 Due: 08/31/29

Developing a Real-Time PCR Assay for Fusobacterium and Epidemiological Analysis of Tumor Patients

Phase: N/A Priority: Normal
NCT ID: NCT06168513 Org: User:
Start: 03/01/23 End: 12/31/24 Due: 12/31/25

Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis

Phase: N/A Priority: Normal
NCT ID: NCT05686447 Org: User:
Start: 01/01/23 End: 07/31/26 Due: 07/31/27

The Construction and Effect Verification of a Deep Learning-based Automated Semantic Segmentation Model for Medical Imaging

Phase: N/A Priority: Normal
NCT ID: NCT06864702 Org: User:
Start: 12/20/23 End: 05/15/25 Due: 05/15/26

Application of Watson for Oncology in Hepatocellular Carcinoma Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03904667 Org: User:
Start: 01/01/17 End: 12/31/21 Due: 12/31/22

Treatment of Unruptured Intracranial Aneurysms in China

Phase: N/A Priority: Normal
NCT ID: NCT03133598 Org: User:
Start: 01/01/16 End: 12/30/22 Due: 12/30/23

Safety and Efficacy of Stent Deployment for Intracranial Aneurysms (SESIA)

Phase: N/A Priority: Normal
NCT ID: NCT03387995 Org: User:
Start: 09/01/16 End: 08/30/24 Due: 08/30/25

Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03098355 Org: User:
Start: 12/30/17 End: 12/31/23 Due: 12/31/24

Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform.

Phase: N/A Priority: Normal
NCT ID: NCT06097065 Org: User:
Start: 05/20/22 End: 12/31/26 Due: 12/31/27

Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT02202239 Org: User:
Start: 09/30/14 End: 08/31/15 Due: 08/31/16

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04354324 Org: User:
Start: 04/20/20 End: 06/30/24 Due: 06/30/25

Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting

Phase: N/A Priority: Normal
NCT ID: NCT06726460 Org: User:
Start: 12/20/24 End: 01/31/25 Due: 01/31/26

A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT03190733 Org: User:
Start: 08/30/17 End: 09/30/21 Due: 09/30/22